Treatment of intracranial atherosclerotic arterial stenoses with a balloon-expandable cobalt chromium stent (Coroflex Blue): Procedural safety, efficacy, and midterm patency

Zsolt Vajda, Elina Miloslavski, Thomas Güthe, Elisabeth Schmid, Christoph Schul, Guido Albes, Hans Henkes

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Introduction: We evaluated the coronary balloon-expandable cobalt chromium stent Coroflex Blue for the treatment of intracranial atherosclerotic arterial stenoses (IAAS). Methods: Between March 2007 and October 2007, a total of 25 patients (20 male, age median 67 years) with 30 IAAS underwent endovascular treatment using Coroflex Blue stents (B. Braun, Germany). Location and degree of target stenoses before and after treatment and at follow-up and adverse clinical sequelae of treatment were registered. Angiographic follow-up was scheduled for 6, 12, 26, and 52 weeks after the treatment. Results: The 30 treated lesions were located as follows: nine in intracranial-extradural internal carotid artery (ICA), three in intradural ICA, five in middle cerebral artery, eight in intradural vertebral artery, and five in basilar artery. The technical success rate was 100%. The degree of stenoses prior to and after treatment was 61∈±∈2% and 26∈±∈3% (mean ± SE), respectively. A residual stenosis of

Original languageEnglish
Pages (from-to)645-651
Number of pages7
JournalNeuroradiology
Volume52
Issue number7
DOIs
Publication statusPublished - Jul 2010

Fingerprint

Chromium
Cobalt
Stents
Pathologic Constriction
Safety
Internal Carotid Artery
Therapeutics
Basilar Artery
Vertebral Artery
Middle Cerebral Artery
Germany

Keywords

  • Atherosclerosis
  • Cobalt chromium
  • Endovascular
  • Intracranial stenosis
  • Stent

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Treatment of intracranial atherosclerotic arterial stenoses with a balloon-expandable cobalt chromium stent (Coroflex Blue) : Procedural safety, efficacy, and midterm patency. / Vajda, Zsolt; Miloslavski, Elina; Güthe, Thomas; Schmid, Elisabeth; Schul, Christoph; Albes, Guido; Henkes, Hans.

In: Neuroradiology, Vol. 52, No. 7, 07.2010, p. 645-651.

Research output: Contribution to journalArticle

Vajda, Zsolt ; Miloslavski, Elina ; Güthe, Thomas ; Schmid, Elisabeth ; Schul, Christoph ; Albes, Guido ; Henkes, Hans. / Treatment of intracranial atherosclerotic arterial stenoses with a balloon-expandable cobalt chromium stent (Coroflex Blue) : Procedural safety, efficacy, and midterm patency. In: Neuroradiology. 2010 ; Vol. 52, No. 7. pp. 645-651.
@article{55241160f00a44bc977bba773072c5f2,
title = "Treatment of intracranial atherosclerotic arterial stenoses with a balloon-expandable cobalt chromium stent (Coroflex Blue): Procedural safety, efficacy, and midterm patency",
abstract = "Introduction: We evaluated the coronary balloon-expandable cobalt chromium stent Coroflex Blue for the treatment of intracranial atherosclerotic arterial stenoses (IAAS). Methods: Between March 2007 and October 2007, a total of 25 patients (20 male, age median 67 years) with 30 IAAS underwent endovascular treatment using Coroflex Blue stents (B. Braun, Germany). Location and degree of target stenoses before and after treatment and at follow-up and adverse clinical sequelae of treatment were registered. Angiographic follow-up was scheduled for 6, 12, 26, and 52 weeks after the treatment. Results: The 30 treated lesions were located as follows: nine in intracranial-extradural internal carotid artery (ICA), three in intradural ICA, five in middle cerebral artery, eight in intradural vertebral artery, and five in basilar artery. The technical success rate was 100{\%}. The degree of stenoses prior to and after treatment was 61∈±∈2{\%} and 26∈±∈3{\%} (mean ± SE), respectively. A residual stenosis of",
keywords = "Atherosclerosis, Cobalt chromium, Endovascular, Intracranial stenosis, Stent",
author = "Zsolt Vajda and Elina Miloslavski and Thomas G{\"u}the and Elisabeth Schmid and Christoph Schul and Guido Albes and Hans Henkes",
year = "2010",
month = "7",
doi = "10.1007/s00234-009-0615-7",
language = "English",
volume = "52",
pages = "645--651",
journal = "Neuroradiology",
issn = "0028-3940",
publisher = "Springer Verlag",
number = "7",

}

TY - JOUR

T1 - Treatment of intracranial atherosclerotic arterial stenoses with a balloon-expandable cobalt chromium stent (Coroflex Blue)

T2 - Procedural safety, efficacy, and midterm patency

AU - Vajda, Zsolt

AU - Miloslavski, Elina

AU - Güthe, Thomas

AU - Schmid, Elisabeth

AU - Schul, Christoph

AU - Albes, Guido

AU - Henkes, Hans

PY - 2010/7

Y1 - 2010/7

N2 - Introduction: We evaluated the coronary balloon-expandable cobalt chromium stent Coroflex Blue for the treatment of intracranial atherosclerotic arterial stenoses (IAAS). Methods: Between March 2007 and October 2007, a total of 25 patients (20 male, age median 67 years) with 30 IAAS underwent endovascular treatment using Coroflex Blue stents (B. Braun, Germany). Location and degree of target stenoses before and after treatment and at follow-up and adverse clinical sequelae of treatment were registered. Angiographic follow-up was scheduled for 6, 12, 26, and 52 weeks after the treatment. Results: The 30 treated lesions were located as follows: nine in intracranial-extradural internal carotid artery (ICA), three in intradural ICA, five in middle cerebral artery, eight in intradural vertebral artery, and five in basilar artery. The technical success rate was 100%. The degree of stenoses prior to and after treatment was 61∈±∈2% and 26∈±∈3% (mean ± SE), respectively. A residual stenosis of

AB - Introduction: We evaluated the coronary balloon-expandable cobalt chromium stent Coroflex Blue for the treatment of intracranial atherosclerotic arterial stenoses (IAAS). Methods: Between March 2007 and October 2007, a total of 25 patients (20 male, age median 67 years) with 30 IAAS underwent endovascular treatment using Coroflex Blue stents (B. Braun, Germany). Location and degree of target stenoses before and after treatment and at follow-up and adverse clinical sequelae of treatment were registered. Angiographic follow-up was scheduled for 6, 12, 26, and 52 weeks after the treatment. Results: The 30 treated lesions were located as follows: nine in intracranial-extradural internal carotid artery (ICA), three in intradural ICA, five in middle cerebral artery, eight in intradural vertebral artery, and five in basilar artery. The technical success rate was 100%. The degree of stenoses prior to and after treatment was 61∈±∈2% and 26∈±∈3% (mean ± SE), respectively. A residual stenosis of

KW - Atherosclerosis

KW - Cobalt chromium

KW - Endovascular

KW - Intracranial stenosis

KW - Stent

UR - http://www.scopus.com/inward/record.url?scp=77955562685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955562685&partnerID=8YFLogxK

U2 - 10.1007/s00234-009-0615-7

DO - 10.1007/s00234-009-0615-7

M3 - Article

C2 - 19921164

AN - SCOPUS:77955562685

VL - 52

SP - 645

EP - 651

JO - Neuroradiology

JF - Neuroradiology

SN - 0028-3940

IS - 7

ER -